Press Releases from Cabozantinib -Pharma Proff (1 total)
Cabozantinib- API Insight, 2018
Cabozantinib, sold under the brand name of Cabometyx and Cometriq, is used for the treatment of medullary thyroid cancer and a second line treatment for…
Go To Page:
